Why technology transfer? President’s presentation of the TT Program
A unique effort to discover new treatments for cancer, the Experimental Therapeutic Unit-IFOM leverages the strong biology and clinical relevance of the whole Campus IFOM and IEO’s research in cancer with industry-competitive drug discovery experience.
TTFactor s.r.l.
Via Adamello, 16 20139 Milano
T: +39 02 94375140
F +39 02 94375991
e-mail:
This email address is being protected from spambots. You need JavaScript enabled to view it.
![]() |
![]() |
![]() |
Read the terms of use of TTFactor website.
TTFactor S.r.l.
Sede legale: Via Ripamonti 435 Milano
Sede Operativa Via Adamello 16 Milano
P.IVA/C.F. 07063660968